HMS
ITCI

Hanseatic Management Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Hanseatic Management Services’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,219
Closed -$583K – 119
2022
Q2 		$583K Buy
10,219
+247
+2% +$14K 1.33% 19
2022
Q1 		$610K Buy
+9,972
New +$518K 1.05% 30
2018
Q4 		– Sell
-42
Closed -$1K – 374
2018
Q3 		$1K Hold
42
– – ﹤0.01% 364
2018
Q2 		$1K Hold
42
– – ﹤0.01% 374
2018
Q1 		$1K Hold
42
– – ﹤0.01% 419
2017
Q4 		$1K Hold
42
– – ﹤0.01% 406
2017
Q3 		$1K Buy
+42
New +$616 ﹤0.01% 397

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hanseatic Management Services's ITCI Position: Q3 2022 in Review

Hanseatic Management Services sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2022, closing a stake of 10,219 shares — an estimated $583K sold.

Hanseatic Management Services first reported a position in ITCI in Q3 2017 and held it in 7 quarters. The position peaked at $610K in Q1 2022. 274 funds tracked by Wall St. Rank hold ITCI as of Q3 2022.

  • Hanseatic Management Services reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 10,219 Intra-Cellular Therapies Inc. shares in Q3 2022, an estimated $583K.
  • Hanseatic Management Services first reported a position in Intra-Cellular Therapies Inc. in Q3 2017 and held it in 7 quarters.
  • Hanseatic Management Services's Intra-Cellular Therapies Inc. position peaked at $610K in Q1 2022.
  • 274 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2022.

Based on Hanseatic Management Services's 13F filing for Q3 2022, filed 8 Nov 2022.